Corcept Therapeutics | Betriebsergebnis



Operating Profit Veränderung Datum
Acadia Pharmaceuticals USD 153.5M 121.86M 2024-12
Alaunos Therapeutics USD -755000 395K 2024-12
ANI Pharmaceuticals USD -4378000 16.14M 2024-12
Ardelyx USD 8.12M 5.89M 2024-12
Aurora Cannabis CAD 36.22M 38.61M 2024-12
BioMarin Pharmaceutical USD 223.89M 62.49M 2025-03
Bristol-Myers Squibb USD 3.41B 2.62B 2025-03
Canopy Growth CAD -23822000 21.8M 2024-12
Corcept Therapeutics USD 25.26M 21.34M 2024-12
Eli Lilly USD 5.41B 259.6M 2025-03
J&J USD 13.63B 9.74B 2025-03
Knight Therapeutics CAD 3.2M 1.29M 2024-09
Merck USD 5.87B 1.57B 2025-03
Novartis USD 2.28B 1.34B 2024-12
Novartis USD 3.4B 193M 2024-12
Pacira USD 24.7M 164.23M 2024-12
Pfizer USD 3.67B 4.08B 2025-03
Supernus Pharmaceuticals USD 21.4M 19.44M 2024-12
TG Therapeutics USD 29.95M 17.52M 2024-12



Corcept Therapeutics Betriebsergebnis - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.